Stocks

Shattuck Labs STTK

Health care sectorNasdaq

What to see in Shattuck Labs now

Is Wall Street adding or cutting?+16

100 13F filers hold it · +16 against the quarter before · shares held +49.4%

Holdings of 06/30
Who bought more than 5%?15.3%

T. Rowe Price Investment Management holds 15.3% · +1.5pp on the report before

Filed 08/14

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Austin, Texas
Fiscal year end
12/31
Next earnings
11/15, estimated
  • 100 13F filers hold it · +16 against the quarter before · shares held +49.4%Holdings of 06/30
  • T. Rowe Price Investment Management holds 15.3% · +1.5pp on the report beforeFiled 08/14

Funds

13F filers: 100 · +16 since the quarter before · 06/30 holdings

Famous funds that held Shattuck Labs in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsShattuck Labs STTK · 06/30 holdings$195.2KNo quarter before
All tracked funds

5% stakes

Holder
T. Rowe Price Investment Management08/1415.3%13,432,540 sh+1.5pp
Redmile Group07/179.9%10,019,421 sh+0.0pp
Deep Track Capital06/175.17%5,000,033 shFirst report
Orbimed Advisors06/159.99%9,021,127 sh+0.0pp
Redmile Group06/119.9%9,819,084 sh+0.0pp
T. Rowe Price Investment Management05/1513.8%9,865,558 sh+2.1pp
T. Rowe Price Investment Management02/0611.7%7,373,891 shFirst report
Orbimed Advisors25/09/029.99%6,306,127 shFirst report
Redmile Group25/08/269.9%6,379,095 sh−1.9pp
Redmile Group25/08/0611.8%5,652,660 shNo earlier report
All 5% stake reports on Shattuck Labs

26-week trading